Health Alliance Plan of Michigan to cover Paradigm Spine’s lumbar spinal stenosis device — 3 insights

Paradigm Spine announced it reached an agreement with the Health Alliance Plan of Michigan to cover the coflex Interlaminar Stabilization device.

Advertisement

Here’s what you should know:

1. Through the agreement, 500,000 Michigan residents will have access to the coflex Interlaminar Stabilization device.

2. Coflex is a nonfusion, motion-preserving, FDA PMA-approved lumbar spinal stenosis treatment.

3. The device can be used in conjunction with decompression or to replace spinal fusion.

Paradigm Spine Chairman and CEO Marc Viscogliosi said in a release, “With over 85 peer review published articles, including landmark five year follow-up studies, medical society guidelines, and now with additional commercial insurance coverage, it is wonderful to be able to expand patient access to the coflex technology.”

More articles on spine:
Tennessee Orthopaedic Alliance surgeon performs 1st outpatient lumbar spinal fusion in region: 5 things to know
Inspired Spine acquires Tristate Brain and Spine Institute, continues finalizing plans to build center with ASC
4 opportunities in outpatient spine from Dr. Frank Phillips

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Outpatient Spine

Advertisement

Comments are closed.